Prnewsnow Reach the World NOW

↑ Grab this Headline Animator

Oridion to Present Integrated Pulmonary Index at European Societyof...



Oridion Systems Ltd. (SIX Swiss Exchange: ORIDN) today announced that it will present its newest capnography technology - Integrated Pulmonary Index (IPI) at the upcoming European Society of Anesthesiology Meeting (ESA) in Milan, Italy. IPI, integrates four complex parameters - end-tidal CO2 (etCO2), respiration rate, pulse rate and SpO2 (oxygen saturation) into a single index value so clinicians can quickly and easily assess a patient'ss ventilatory status.



IPI provides an early indication of changes in the patient'ss ventilatory status that may not be indicated by the current value of any of these four parameters individually. With IPI, clinicians can quickly and easily assess a patient'ss ventilation status and monitor a patient'ss changing condition, thus facilitating more timely interventions to reduce patient risk, improve outcomes and increase patient safety.



The Integrated Pulmonary Index will be introduced at the Capnography Symposium at the ESA Meeting on Sunday, June 7, 2009 between 12:15 - 13:45 at the Pink 3 hall, and at the Oridion booth C-19. The symposium moderated by ESA President, Prof. Hans Knape from the University Medical Center of Utrecht will also include presentations on improved monitoring for patient safety in sedation procedures by Profs. Baruch Krauss, Yaacov Gozal and Cor Kalkman. For more details, click here (http://www.oridion.com/global/english/news/Events/EAS2009.html).



Prof. Yaacov Gozal, from Shaare Zedek Medical Center will also present his new study, conducted with David Gozal, MD, entitled Validation of the Integrated Pulmonary Index in the Post Anesthesia Care Unit. The study concluded that IPI has been shown to correlate with the respiratory status of adult patients after surgery. Since it is displayed as a single value, it may simplify the monitoring of patients in a busy PACU.



IPI can be found only in Microstream Capnography equipped patient monitors, specifically in the Capnostream's8482;20 monitors. Oridion received an FDA 510(k) clearance for its Capnostream's8482;20 monitor with Integrated Pulmonary Index earlier this year.



Oridion is the global leader of innovative capnography monitoring solutions helping to improve patient safety, and its Microstream's174; capnography technology has become the standard of care in ventilation monitoring.



For further Oridion information please contact


Alan Adler, Chairman and Chief Executive Officer


Walter Tabachnik, Chief Financial Officer


Elena Gerberg, Investor Relations



e-mail: info(at)oridion.com


website: www.oridion.com


phone: +972 2 589 9159


address: Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel



About Oridion


Oridion Systems Ltd. (www.oridion.com) is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States, Europe, and Israel.



Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream's174; technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient'ss breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, operating rooms, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients's ventilation may be compromised and at risk.



Certain statements made herein that are not historical are forward-looking. The words estimate project intend expect believe and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties. Many factors could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, our ability to maintain profits, the market demands for our Capnography products, our ability to focus our team on the Capnography business, changes in general economic and business conditions, inability to maintain market acceptance to the Company'ss products, inability to timely develop and introduce new technologies, products and applications, rapid changes in the market for the Company'ss products, loss of market share and pressure on prices resulting from competition, introduction of competing products by other companies, inability to manage growth and expansion, loss of key OEM partners, inability to attract and retain qualified personnel, inability to protect the Company'ss proprietary technology.



The Company does not assure any obligation to update the forward looking information contained in this press release.






Prnewsnow Reach the World NOW

↑ Grab this Headline Animator

This article has been robotically scanned and tagged by Prnewsnow with the following search tags. No human manipulation of these tags take place.
| Checkpoint | Checkpointhr Com | throughout entire employee |




Last 1000 Articles Submitted XML FEEDS FOR ORGANIZED NEWS